XDWY:XETRA:XETRA-Xtrackers MSCI World ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 22.49

Change

+0.01 (+0.04)%

Market Cap

USD 0.09B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.48 (+0.95%)

USD 420.85B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.16 (+0.96%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.82%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.27 (+0.96%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.29 (+1.18%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.35 (+0.78%)

USD 102.32B
8R80:XETRA Amundi Index Solutions - Amund..

+1.10 (+0.77%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.53 (+1.07%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.08 (+0.08%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.16 (+0.20%)

USD 80.38B

ETFs Containing XDWY:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.51% 79% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.51% 79% B- 79% B-
Trailing 12 Months  
Capital Gain 32.01% 78% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.01% 78% C+ 78% C+
Trailing 5 Years  
Capital Gain 29.15% 50% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.15% 50% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 6.63% 55% F 54% F
Dividend Return 7.77% 59% D- 57% F
Total Return 1.13% 71% C- 50% F
Risk Return Profile  
Volatility (Standard Deviation) 11.99% 52% F 61% D-
Risk Adjusted Return 64.80% 63% D 67% D+
Market Capitalization 0.09B 30% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.